Mirion Technologies MIR Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Total revenues by Business | ||||||
| Medical | $80.6M-0.7% | $72.1M+5.1% | $82.5M-3.6% | $78.5M+5.9% | $81.2M+10.9% | |
| Nuclear & Safety | $186.2M+31.4% | $185.5M+39.1% | $194.9M+15.5% | $144.6M+9.0% | $141.7M+5.8% | |
| Total revenues by Product | ||||||
| Cancer care | $62.8M+1.0% | $55.3M+8.4% | $63.9M-3.2% | $62M+8.6% | $62.2M+11.1% | |
| Labs and research | $29.1M+6.2% | $28.3M+5.6% | $34M-7.1% | $34M-4.0% | $27.4M+2.6% | |
| Nuclear | $118.1M+43.8% | $125.8M+49.6% | —— | —— | $82.1M— | |
| Other | $17.8M-44.7% | $16.8M-25.3% | $34.4M+0.3% | $28.8M+10.8% | $32.2M+3.2% | |
| Total revenues by Geography | ||||||
| Asia Pacific | $2.6M+18.2% | $4.7M-19.0% | $4.4M+46.7% | $3.2M+10.3% | $2.2M+83.3% | |
| Europe | $85.1M+4.0% | $77.9M+18.9% | $104.7M+9.6% | $75.7M+15.9% | $81.8M+6.1% | |
| North America | $179.1M+28.9% | $175M+33.9% | $168.3M+8.0% | $144.2M+4.0% | $138.9M+7.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Mirion Technologies break its business down?
- Mirion Technologies (MIR) reports total revenues by business across 2 parts — Medical and Nuclear & Safety. Each is extracted from the segment footnotes and tracked over time.
- Where does Mirion Technologies's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Mirion Technologies's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
